Tribe, Drugmaker Ask Justices To Overturn Bar On Sovereign Immunity IPR Protection
Mealey's (January 15, 2019, 2:45 PM EST) -- WASHINGTON, D.C. — The Federal Circuit U.S. Court of Appeals’ ruling that an Indian tribe’s sovereign immunity cannot shield a drug company from inter partes review (IPR) of patents should be...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login